Stay updated on Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial

Sign up to get notified when there's something new on the Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:42:14.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to a Phase 1/2 gene therapy study for severe Haemophilia A patients conducted by BioMarin Pharmaceutical Inc.
    Difference
    0.2%
    Check dated 2024-06-06T14:31:42.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that males 18 years or older with severe Haemophilia A are eligible, along with other specific health and treatment conditions.
    Difference
    26%
    Check dated 2024-05-22T21:23:42.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:28:40.000Z thumbnail image

Stay in the know with updates to Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial page.